CCR1 and renal fibrosis: BX471, a CCR1 blocker, reduced renal fibrosis in mice of UUO by decreasing the T cell infiltration, which represented that blocking chemokines and respective receptors might be a potential therapeutic strategy for alleviating renal fibrosis (Anders et al., 2002).